Advances on the role of stem cells in liver cancer DOI
Yang Wang, Jia-Ping Wang

Deleted Journal, Journal Year: 2024, Volume and Issue: unknown, P. 1 - 12

Published: Dec. 31, 2024

Liver cancer, especially hepatocellular carcinoma (HCC), is one of the most common malignant tumors worldwide, and its high mortality rate treatment difficulty have always been major challenges faced by medical community. With continuous development biotechnology, stem cell research has shown great potential hope in liver cancer treatment. This review provides a brief overview importance cells research, including identification (LCSCs), molecular maintenance mechanisms stemness LCSCs, targeted therapy strategies, as well therapy, proposing future directions.

Language: Английский

New perspectives on arteriosclerosis treatment using nanoparticles and mesenchymal stem cells DOI Creative Commons
Simin Farokhi,

ZahraSadat Razavi,

Maryamosadat Mavaei

et al.

Deleted Journal, Journal Year: 2024, Volume and Issue: 6(8)

Published: July 29, 2024

Abstract Arteriosclerosis (AS) presents a significant global health challenge, demanding innovative therapeutic strategies. This review explores the potential of nanoparticles (NPs) and mesenchymal stem cells (MSCs) as promising modalities for treating AS. NPs enable targeted drug delivery, while MSCs possess immunomodulatory regenerative capabilities. We discuss recent advances in NP-based delivery systems tailored AS treatment highlight MSCs’ roles modulating inflammation promoting vascular repair. Additionally, we examine synergistic effects combining enhanced outcomes. Furthermore, this paper provides insights into targeting endothelial cells, T-cells, macrophages, lipid levels, plaques using MSCs. It also reviews various types metal-based non-metallic utilized therapy. comprehensive overview underscores synergies between cardiovascular disease therapy, emphasizing need further research to fully realize their implications. Graphical

Language: Английский

Citations

13

hAMSCs regulate EMT in the progression of experimental pulmonary fibrosis through delivering miR-181a-5p targeting TGFBR1 DOI Creative Commons
Yanyang Wang, Chan Liu, Nuoxin Wang

et al.

Stem Cell Research & Therapy, Journal Year: 2025, Volume and Issue: 16(1)

Published: Jan. 5, 2025

Pulmonary fibrosis (PF) is a common and multidimensional devastating interstitial lung disease. The development of novel more effective interventions for PF an urgent clinical need. A previous study has found that miR-181a-5p plays important role in the PF, human amniotic mesenchymal stem cells (hAMSCs) exert potent therapeutic potential on PF. However, whether hAMSCs act by delivering its detailed mechanism still remain unknown. Thus, this was designed to investigate underlying possible bleomycin (BLM)-induced mouse model, co-culture system A549 epithelial transition (EMT) focusing effects collagen deposition, EMT, cell cycle regulation. with different expression levels were constructed. BLM (4 mg/kg) used create while TGF-β1 induce construct EMT model. Furthermore, deposition during assessed vivo vitro. We exerted anti-fibrotic effect BLM-induced Moreover, also protective TGFβ1-induced ameliorated promoting proliferation, reducing apoptosis, attenuating through paracrine effects. regulated targeting TGFBR1. Our findings reveal first time inhibit EMT. Mechanistically, hMASCs achieved

Language: Английский

Citations

1

Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases DOI Creative Commons
Adriana Jiménez, Enrique Estudillo, Mara A. Guzmán‐Ruiz

et al.

Pharmaceutics, Journal Year: 2025, Volume and Issue: 17(3), P. 281 - 281

Published: Feb. 20, 2025

The blood–brain barrier (BBB) is a critical structure that maintains brain homeostasis by selectively regulating nutrient influx and waste efflux. Not surprisingly, it often compromised in neurodegenerative diseases. In addition to its involvement these pathologies, the BBB also represents significant challenge for drug delivery into central nervous system. Nanoparticles (NPs) have been widely explored as carriers capable of overcoming this effectively transporting therapies brain. However, their potential directly address ameliorate dysfunction has received limited attention. review, we examine how NPs enhance across treat diseases explore emerging strategies restore integrity vital structure.

Language: Английский

Citations

1

Exploring the therapeutic potential of different sources of mesenchymal stem cells: a novel approach to combat burn wound infections DOI Creative Commons

Shahrzad Aliniay-Sharafshadehi,

Mohammad Hasan Yousefi,

Mohammad Ghodratie

et al.

Frontiers in Microbiology, Journal Year: 2024, Volume and Issue: 15

Published: Nov. 29, 2024

The most prevalent and harmful injuries are burns, which still a major global health problem. Burn can cause issues because they boost the inflammatory metabolic response, organ malfunction systemic failure. On other hand, burn wound infection creates an environment that is conducive to growth of bacteria might put patient at risk for sepsis. In addition, scarring unavoidable, this results in patients having functional cosmetic issues. Wound healing amazing phenomenon with complex mechanism deals different types cells biomolecules. Cell therapy using stem one challenging treatment methods accelerates wounds. Since 2000, use mesenchymal (MSCs) regenerative medicine has increased. They be extracted from various tissues, such as bone marrow, fat, umbilical cord, amniotic membrane. According studies, cell wounds increases angiogenesis, anti-inflammatory properties, slows progression fibrosis, excellent ability differentiate regenerate damaged tissue. Figuring out main preclinical clinical problems stop people MSCs then suggesting right ways improve could help show benefits move cell-based forward. This review's objective was assess therapy's contribution promotion healing.

Language: Английский

Citations

6

Cryo-Trojan Mesenchymal Stem Cells as Non-Living Tumor-Homing Supercarriers for Enhanced Drug Delivery and Immune Activation in Prostate Cancer DOI Creative Commons

Chengran Wang,

Xianfang Rong,

Fuqiang Zhang

et al.

Materials Today Bio, Journal Year: 2025, Volume and Issue: 32, P. 101650 - 101650

Published: March 12, 2025

Prostate cancer remains a leading cause of cancer-related mortality, with conventional therapies limited by systemic toxicity and poor tumor targeting. Developing innovative drug delivery systems that enhance therapeutic specificity while minimizing off-target effects is critical. We engineered cryo-trojan human umbilical cord mesenchymal stem cells (CT-MSCs) as non-living, tumor-homing carriers for mitoxantrone (MTX), termed CT-MTX. Cryo-treatment preserved structural integrity chemokine receptors (CXCR4/CCR2) targeting eliminating proliferative risks. Comprehensive evaluations included loading/release kinetics, in vitro suppression, immunogenic cell death (ICD) induction, vivo efficacy/safety prostate models. CT-MTX demonstrated superior loading (116.38 μg/106 cells) pH-sensitive release (74.10 % at pH 5.5), outperforming exosomes, liposomes, living MSCs stability tumor-specific delivery. Compared to liposomes (low targeting) nanomaterials (biocompatibility concerns), leveraged MSC-derived tropism without tumorigenic In vitro, inhibited proliferation (84.83 MTX uptake), migration (4.42 residual migration), induced apoptosis (43.23 late apoptosis). Mechanistically, triggered ICD via PAMPs release, activating CD8+ T suppressing immunosuppressive Treg. vivo, selectively accumulated tumors, reducing growth 87.88 extending survival (93.30 vs. 66.70 controls) negligible toxicity. Proteomics revealed enriched immune pathways like NK cytotoxicity, validating its dual role direct killing activation. represents novel, non-proliferative platform combines the capacity enhanced safety controlled inducing ICDs other immunologically "cold" tumors improve infiltration.

Language: Английский

Citations

0

MSC-derived extracellular vesicles: Precision miRNA delivery for overcoming cancer therapy resistance DOI
Ahsas Goyal, Muhammad Afzal,

Kavita Goyal

et al.

Regenerative Therapy, Journal Year: 2025, Volume and Issue: 29, P. 303 - 318

Published: April 5, 2025

Language: Английский

Citations

0

Hematopoietic stem cell conditioned media induces apoptosis in colorectal cancer stem cells via dysregulation of HSP90 and 26S proteasome system DOI

Sumit Mallick,

Vanya Kadla Narayana, Akhila Balakrishna

et al.

The International Journal of Biochemistry & Cell Biology, Journal Year: 2025, Volume and Issue: unknown, P. 106773 - 106773

Published: April 1, 2025

Language: Английский

Citations

0

Recent advances in gold nanoparticle-graphene hybrid nanoplatforms with visible to near-infrared response for photodynamic and photothermal therapy and bioimaging DOI Creative Commons
Alexandru Holca, Vlad Cucuiet, Simion Aştilean

et al.

RSC Advances, Journal Year: 2025, Volume and Issue: 15(15), P. 11902 - 11922

Published: Jan. 1, 2025

Graphene oxide (GO) and reduced graphene (rGO) with gold nanoparticles (GNPs) enhance phototherapy, leveraging the NIR-I NIR-II optical biological windows for improved tissue penetration targeted cancer treatment.

Language: Английский

Citations

0

Nano Delivery Systems in Stem Cell Therapy: Transforming Regenerative Medicine and Overcoming Clinical Challenges DOI Creative Commons

R Aswini,

R Rithi Angelin,

B Saranya

et al.

Nano TransMed, Journal Year: 2024, Volume and Issue: unknown, P. 100069 - 100069

Published: Dec. 1, 2024

Language: Английский

Citations

2

Targeting the tumor microenvironment with mesenchymal stem cells based delivery approach for efficient delivery of anticancer agents: An updated review DOI
Yu Yang, Tao Ying,

Jingru Ma

et al.

Biochemical Pharmacology, Journal Year: 2024, Volume and Issue: unknown, P. 116725 - 116725

Published: Dec. 1, 2024

Language: Английский

Citations

2